Correction to Lancet Oncol 2015; 16: 747. EGFR mutations and EGFR tyrosine kinase inhibitors

Lancet Oncol. 2015 Jul;16(7):e313. doi: 10.1016/S1470-2045(15)00082-0.
No abstract available

Publication types

  • Published Erratum